Wall Street expects Elevance Health to post $11.09 EPS and $45.93 billion in revenue, reflecting solid year-over-year growth.

Elevance Health’s stock has danced a bit faster than its actual financial performance over the past five years, delivering a 68% rise in share price despite a more modest 7% annual EPS growth. This ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 4.67%, which means the company has less short interest than most of its peers. Did you ...

Investors in Elevance Health, Inc. ELV need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $270 Call had some of the highest implied ...